Active ingredientTaurolidineCat. No. P-T020-001CAS 19388-87-5Family · Pharmaceutical analytical standards
Taurolidine
An antimicrobial derived from the amino acid taurine, synthesised in 1972 in Switzerland and studied from 1975 against peritonitis: it is used to prevent infections of venous catheters, and in the United States it was approved in 2023, combined with heparin, for haemodialysis catheters. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.
Did you know?In the body it breaks down into taurine, carbon dioxide and water, and it acts by releasing chemical groups similar to formaldehyde; in various studies, bacterial resistance has never been observed.
Go to the active ingredient →Active ingredientTaurolidineCat. No. P-T020-001CAS 19388-87-5
Isotopically labelledTaurolidine-d6Cat. No. P-T020-003
NitrosamineN-Nitroso TaurolidineCat. No. P-T020-004
Impurity3-Aminopropane-1-sulfonamide HydrochlorideCat. No. P-T020-006CAS 74494-51-2
ImpurityTaurinamide HClCat. No. P-T020-007CAS 89756-60-5
ImpurityTaurolidine Impurity 1Cat. No. P-T020-008CAS 19388-88-6
ImpurityTaurultamCat. No. P-T020-010CAS 38668-01-8No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.